Press Releases

Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock

Nov 29, 2019

Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock

Nov 26, 2019

Sonoma Pharmaceuticals Announces Proposed Public Offering of Common Stock

Nov 25, 2019

Sonoma Pharmaceuticals Reports Second Quarter FY 2020 Financial Results

Nov 14, 2019

Sonoma Pharmaceuticals Announces Management Changes

Oct 1, 2019

Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results

Aug 13, 2019

Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule

Jul 12, 2019

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results

Jul 8, 2019

Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock

Jun 19, 2019

Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 million

May 21, 2019